MedPath

Chlorzoxazone

Generic Name
Chlorzoxazone
Brand Names
Lorzone, Parafon Forte
Drug Type
Small Molecule
Chemical Formula
C7H4ClNO2
CAS Number
95-25-0
Unique Ingredient Identifier
H0DE420U8G
Background

A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)

Indication

For the relief of discomfort associated with acute painful musculoskeletal conditions.

Associated Conditions
Acute painful musculoskeletal conditions

Pharmacokinetic and Bioequivalence Comparison of Baclofen and Chlorzoxazone Administered Individually or Concurrently

First Posted Date
2022-02-25
Last Posted Date
2023-03-31
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
19
Registration Number
NCT05257447
Locations
🇺🇸

UT Southwestern Medical Center, Dallas, Texas, United States

A Study to Investigate the Potential Influence of Nitisinone on the Metabolism and the Transport of Other Drugs in Healthy Volunteers

First Posted Date
2017-04-06
Last Posted Date
2017-08-10
Lead Sponsor
Swedish Orphan Biovitrum
Target Recruit Count
36
Registration Number
NCT03103568
Locations
🇩🇪

PAREXEL EPCU Berlin, Berlin, Germany

Chlorzoxazone in Hip and Knee Arthroplasty

Phase 4
Completed
Conditions
Osteoarthritis of Hip
Osteoarthritis, Knee
Interventions
Drug: Placebo
Procedure: TKA
Procedure: THA
First Posted Date
2015-04-01
Last Posted Date
2019-09-09
Lead Sponsor
Northern Orthopaedic Division, Denmark
Target Recruit Count
400
Registration Number
NCT02405104
Locations
🇩🇰

Northern Orthopaedic Division, Clinic Farsø, Aalborg University Hospital, Farsø, Northern Jutland, Denmark

The Effect of Chlorzoxazone on Moderate to Severe Postoperative Pain After Spine Surgery

Phase 4
Completed
Conditions
Chlorzoxazone
Postoperative Pain
Interventions
First Posted Date
2013-09-02
Last Posted Date
2015-09-17
Lead Sponsor
Rigshospitalet, Denmark
Target Recruit Count
110
Registration Number
NCT01933542
Locations
🇩🇰

Glostrup University Hospital, Glostrup, Denmark

Placebo-Controlled Cross Over Trial of Chlorzoxazone Intake

Phase 4
Completed
Conditions
Alcohol Abuse
Interventions
First Posted Date
2011-04-27
Last Posted Date
2020-11-20
Lead Sponsor
University of California, San Francisco
Target Recruit Count
48
Registration Number
NCT01342341
Locations
🇺🇸

Ernest Gallo Clinic and Research Center, Emeryville, California, United States

Pharmacokinetic Study to Investigate Low-dose Combinations of a Cocktail of Seven Drugs for Simultaneous Phenotyping of Cytochromes

Phase 1
Completed
Conditions
Cytochrome
Pharmacokinetics
Interventions
First Posted Date
2010-08-24
Last Posted Date
2015-04-17
Lead Sponsor
University Hospital, Basel, Switzerland
Target Recruit Count
16
Registration Number
NCT01187862
Locations
🇨🇭

University Hospital, Basel, Switzerland

© Copyright 2025. All Rights Reserved by MedPath